Its LegitScript certification and pharmacy partnerships position it better than unregulated operations
Key Benefits: Supports natural GLP-1 activity* for appetite control and metabolic support
In the direct comparison of tirzepatide versus semaglutide, we observed CIs compatible with no difference and point estimates indicating a modest numeric advantage of semaglutide, if any, for reducing MACE, particularly among patients at high cardiovascular risk
Zepbound was also approved for obstructive sleep apnea (OSA) in December 2024 for adults with moderate-to-severe OSA and obesity
Depending on the severity and location, a stable horizontal tear may heal without surgery
Metabolic disorders, including diabetes, uremia, and low sodium, can play a role, and cardiac problems such as heart attack or pericarditis are also linked